4,034
Views
13
CrossRef citations to date
0
Altmetric
Research Article

In vitro characterization of TMPRSS2 inhibition in IPEC-J2 cells

, , , , &
Pages 123-129 | Received 08 Feb 2016, Accepted 17 May 2016, Published online: 09 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Erzsébet Pászti-Gere, Judit Pomothy, Ákos Jerzsele, Oliver Pilgram & Torsten Steinmetzer. (2021) Exposure of human intestinal epithelial cells and primary human hepatocytes to trypsin-like serine protease inhibitors with potential antiviral effect. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 659-668.
Read now

Articles from other publishers (12)

Nicholas van Eijk, Luna C. Schmacke, Torsten Steinmetzer, Oliver Pilgram, Miklós Poór & Erzsébet Pászti-Gere. (2023) In vitro testing of host-targeting small molecule antiviral matriptase/TMPRSS2 inhibitors in 2D and 3D cell-based assays. Biomedicine & Pharmacotherapy 168, pages 115761.
Crossref
Cecilia Pozzi, Anne Vanet, Valeria Francesconi, Lorenzo Tagliazucchi, Giusy Tassone, Alberto Venturelli, Francesca Spyrakis, Marco MazzoranaMaria P. Costi & Michele Tonelli. (2023) Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery–Genetics Alliance Perspective. Journal of Medicinal Chemistry 66:6, pages 3664-3702.
Crossref
Zsófia Fedor, Anna Szentkirályi-Tóth, Gábor Nagy, Zoltán Szimrók, Eszter Varga, Anna Pászti, Zoltán Pászti, Ákos Jerzsele, Oliver Pilgram, Torsten Steinmetzer, Gábor Mátis, Zsuzsanna Neogrády & Erzsébet Pászti-Gere. (2022) Interspecies Comparisons of the Effects of Potential Antiviral 3-Amidinophenylalanine Derivatives on Cytochrome P450 1A2 Isoenzyme. Veterinary Sciences 9:4, pages 156.
Crossref
Erzsébet Pászti-Gere, Anna Szentkirályi, Zsófia Fedor, Gábor Nagy, Zoltán Szimrók, Zoltán Pászti, Anna Pászti, Oliver Pilgram, Torsten Steinmetzer, Slávka Bodnárová, Eszter Fliszár-Nyúl & Miklós Poór. (2022) In vitro interaction of potential antiviral TMPRSS2 inhibitors with human serum albumin and cytochrome P 450 isoenzymes. Biomedicine & Pharmacotherapy 146, pages 112513.
Crossref
Ya-Ming Xu, Marielle Cascaes Inacio, Manping X. Liu & A.A. Leslie Gunatilaka. (2022) Discovery of diminazene as a dual inhibitor of SARS-CoV-2 human host proteases TMPRSS2 and furin using cell-based assays. Current Research in Chemical Biology 2, pages 100023.
Crossref
Filipa Santos, Pedro Fernandes & Maria Ramos. (2021) Enzima TMPRSS2. Revista de Ciência Elementar 9:4.
Crossref
Anna Goc, Waldemar Sumera, Matthias Rath & Aleksandra Niedzwiecki. (2021) Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions. PLOS ONE 16:6, pages e0253489.
Crossref
Jacopo Sgrignani & Andrea Cavalli. (2021) Computational Identification of a Putative Allosteric Binding Pocket in TMPRSS2. Frontiers in Molecular Biosciences 8.
Crossref
Abdul Arif Khan & Zakir Khan. (2021) Comparative host–pathogen protein–protein interaction analysis of recent coronavirus outbreaks and important host targets identification. Briefings in Bioinformatics 22:2, pages 1206-1214.
Crossref
Anna Goc, Aleksandra Niedzwiecki & Matthias Rath. (2021) Polyunsaturated ω-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry. Scientific Reports 11:1.
Crossref
Tianguang Huang, Lin Sun, Dongwei Kang, Vasanthanathan Poongavanam, Xinyong Liu, Peng Zhan & Luis Menéndez-Arias. 2021. Antiviral Drug Discovery and Development. Antiviral Drug Discovery and Development 219 260 .
Steve P.H. Alexander, Jane F. Armstrong, Anthony P. Davenport, Jamie A. Davies, Elena Faccenda, Simon D. Harding, Francesca Levi‐Schaffer, Janet J. Maguire, Adam J. Pawson, Christopher Southan & Michael Spedding. (2020) A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development: IUPHAR Review 29. British Journal of Pharmacology 177:21, pages 4942-4966.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.